Ocellaris Pharma, Inc.
1 clinical trials · Sponsor
◉ Watch Ocellaris Pharma, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers (NCT04260802) | Ocellaris Pharma, Inc. | 2020-09-24 |
Track Ocellaris Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.